Germany· DE-A57-ac749dd38671a139
Carbamazepin Puren
A carbamazepine product containing carbamazepine, registered in Germany by Puren Pharma Gmbh & Co. Kg. The same ATC class is registered in 18 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Carbamazepine is registered in 18 of 19 countries.
Countries holding a registration under ATC N03AF01 (carbamazepine), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 10 of them publish a price we can compare per daily dose
Carbamazepine · ATC N03AF01
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of carbamazepine costs, country by country.
Normalised to the WHO defined daily dose (1 g), the median price runs from $0.39 in France to $1.99 in United States — a ×5.2 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Carbamazepine · price per daily dose (1 g)
USD · FX 28 Sept 2026
- US United States$1.99 (acquisition cost)
- CH Switzerland$1.35
- IT Italy$0.46
- FR France$0.39
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Carbamazepine
- Manufacturer
- Puren Pharma Gmbh & Co. Kg
- Country
- Germany (DE)
- ATC code
- N03AF01
- ATC class
- Carbamazepine
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- July 8, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
614 interactions on record for carbamazepine.
Graded by severity as the source publishes them — 136 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Carbamazepine · interactions on record
614 records
- 136 severe
- 250 moderate
- 6 minor
- 133 info
Most severe, free to view
- RolapitantA04AD14severe
- NaloxegolA06AH03severe
- NaldemedineA06AH05severe
- EliglustatA16AX10severe
89 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Carbamazepine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCarbamazepinUpsher-Smith Laboratories, LLC
- United KingdomArbil MR 200mg tabletsSun Pharma UK Ltd
- SwedenCarbamazepine Essential Pharma 125 mg SuppositoriumEssential Pharma (M) Ltd
- FinlandCarbamazepin BiochemieSandoz GmbH
- NetherlandsCarbamazepine 100 mg Focus Care, tablettenFocus Care Pharmaceuticals B.V.
- SwitzerlandTegretol 2%, Suspension zum EinnehmenNovartis Pharma Schweiz AG
- CzechiaBISTONZentiva, k.s., Praha
- NorwayCarbamazepine Essential PharmaEssential Pharma (M) Limited
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Neurotop, Neurotop Retard
- Belgium · Tegretol, Tegretol Cr
- Bulgaria · Neurotop, Neurotop Retard
- Cyprus · Storilat, Storilat R
- Czechia · Biston, Neurotop
- Denmark · Tegretol, Tegretol Retard
- Estonia · Carbalex, Carbalex Retard
- Spain · Carbamazepina Normon, Carbamazepina Vegal
- Finland · Carbamazepine Essential Pharma, Neurotol Slow
- France · Carbamazepine L.P. Sandoz, Carbamazepine Viatris
- United Kingdom (Northern Ireland) · Carbagen, Carbamazepine
- Greece · Tegretol
- Croatia · Karbamazepin Tillomed, Tegretol
- Hungary · Carbamazepine Essential Pharma, Neurotop
- Ireland · Carbamazepine Azure Pharmaceuticals, Carbamazepine Essential Pharma
- Iceland · Tegretol, Tegretol Retard
- Italy · Carbamazepina Aurobindo, Carbamazepina Eg
- Lithuania · Carbalex, Carbatol
- Luxembourg · Tegretol, Tegretol Cr
- Latvia · Carbalex, Carbalex Retard
- Malta · Tegretol, Tegretol Cr
- Netherlands · Carbamazepine Aurobindo, Carbamazepine Cf
- Norway · Carbamazepine Essential Pharma, Tegretol
- Poland · Amizepin, Finlepsin
- Portugal · Carbamazepina Generis, Carbamazepina Generis Phar
- Romania · Carbamazepin Bioeel, Carbamazepină Arena
- Sweden · Carbamazepine Essential Pharma, Carbamazepine Tillomed
- Slovenia · Tegretol, Tegretol Cr
- Slovakia · Biston, Neurotop Retard
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d7e3d8b1-3b83-4b4a-99e7-095ee3a50e80 GET /v1/drugs/d7e3d8b1-3b83-4b4a-99e7-095ee3a50e80?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Carbamazepine",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about carbamazepine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.